Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle

Running, not enrolling · Not applicable

Conditions studied: Osteoarthritis Ankle, Osteoarthritis Foot

In brief

The purpose of this study is to determine if Electromagnetic Transduction Therapy (EMTT) is a viable treatment option in patients with osteoarthritis of the foot and/or ankle.

Key facts

Study ID

NCT06696118

Run by

Mayo Clinic

People needed

20

Starts

2025-03-13

Expected to finish

2027-01-01

Last updated by the study team

2026-05-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women with osteoarthritis of the foot and/or ankle confirmed via radiographs.

You may not qualify if…

• Pacemaker, active cancer, shrapnel, metal in eye, implantable devices that are not compatible with MRIs, concurrent foot or ankle condition or injury, prior foot or ankle surgery for osteoarthritis, steroid, platelet rich plasma, or hyaluronic acid injection within 2 months of the treatment.

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.